Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations
John W. Scott, Simon A. Hawley, Kevin A. Green, Miliea Anis, Greg Stewart, Gillian A. Scullion, David G. Norman, D. Grahame Hardie
John W. Scott, Simon A. Hawley, Kevin A. Green, Miliea Anis, Greg Stewart, Gillian A. Scullion, David G. Norman, D. Grahame Hardie
View: Text | PDF
Article Genetics

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations

  • Text
  • PDF
Abstract

CBS domains are defined as sequence motifs that occur in several different proteins in all kingdoms of life. Although thought to be regulatory, their exact functions have been unknown. However, their importance was underlined by findings that mutations in conserved residues within them cause a variety of human hereditary diseases, including (with the gene mutated in parentheses): Wolff-Parkinson-White syndrome (γ2 subunit of AMP-activated protein kinase); retinitis pigmentosa (IMP dehydrogenase-1); congenital myotonia, idiopathic generalized epilepsy, hypercalciuric nephrolithiasis, and classic Bartter syndrome (CLC chloride channel family members); and homocystinuria (cystathionine β-synthase). AMP-activated protein kinase is a sensor of cellular energy status that is activated by AMP and inhibited by ATP, but the location of the regulatory nucleotide-binding sites (which are prime targets for drugs to treat obesity and diabetes) was not characterized. We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β-synthase bind AMP, ATP, or S-adenosyl methionine,while mutations that cause hereditary diseases impair this binding. This shows that tandem pairs of CBS domains act, in most cases, as sensors of cellular energy status and, as such, represent a newly identified class of binding domain for adenosine derivatives.

Authors

John W. Scott, Simon A. Hawley, Kevin A. Green, Miliea Anis, Greg Stewart, Gillian A. Scullion, David G. Norman, D. Grahame Hardie

×

Figure 8

Options: View larger image (or click on image) Download as PowerPoint
Model of the N-terminal pair of CBS domains (CBS1 and CBS2) from the γ2 ...
Model of the N-terminal pair of CBS domains (CBS1 and CBS2) from the γ2 subunit of AMPK. The picture is a view of a molecular-surface representation made using the program GRASP (Department of Biochemistry, Columbia University, New York, New York, USA) (51), with CBS1 on the left. The model was made using MODELLER 6 (Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, California, USA) (52) and was based on the atomic coordinates of the CBS domain pair from a bacterial IMPDH (Protein Data Bank code 1ZFJ) (34). Electrostatic potential at the surface is depicted as red for negative and blue for positive. The approximate positions of residues mutated in WPWS are shown. R302 and H383 occupy equivalent positions in CBS1 and CBS2, respectively, and are adjacent to each other in the model. Part of residue T400 projects into the hydrophobic cleft between the two domains.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts